Inventor
NAYLER OLIVER
CH40 patents
⚠️ This page may combine multiple inventors who share the name “NAYLER OLIVER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACTELION PHARMACEUTICALS LTD
20 patentsUS7435828B2Oct 14, 2008
Thiazolidin-4-one derivatives
ACTELION PHARMACEUTICALS LTD33 citations96
US9000018B2Apr 7, 2015
Thiazolidin-4-one-derivatives
ACTELION PHARMACEUTICALS LTD13 citations92
USRE45174ESep 30, 2014
Thiazolidin-4-one derivatives
ACTELION PHARMACEUTICALS LTD14 citations92
US7875726B2Jan 25, 2011
Thiazolidin-4-one derivatives
ACTELION PHARMACEUTICALS LTD24 citations92
US7626037B2Dec 1, 2009
Thiazolidin-4-one derivatives
ACTELION PHARMACEUTICALS LTD24 citations92
US8003800B2Aug 23, 2011
Thiophene derivatives as S1P1/EDG1 receptor agonists
ACTELION PHARMACEUTICALS LTD18 citations84
US7981924B2Jul 19, 2011
Thiophene derivatives
ACTELION PHARMACEUTICALS LTD8 citations84
US7750040B2Jul 6, 2010
Thiophene derivatives
ACTELION PHARMACEUTICALS LTD17 citations84
US7723378B2May 25, 2010
Hydrogenated benzo (C) thiophene derivatives as immunomodulators
ACTELION PHARMACEUTICALS LTD16 citations84
US7605269B2Oct 20, 2009
Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
ACTELION PHARMACEUTICALS LTD15 citations84
US8044076B2Oct 25, 2011
Phenyl derivatives and their use as immunomodulators
ACTELION PHARMACEUTICALS LTD13 citations83
US7846964B2Dec 7, 2010
Thiophene derivatives as spingosine-1-phosphate-1 receptor agonists
ACTELION PHARMACEUTICALS LTD11 citations82
US9617250B2Apr 11, 2017
Pyridin-4-yl derivatives
ACTELION PHARMACEUTICALS LTD4 citations73
US10251867B2Apr 9, 2019
Dosing regimen for a selective S1P1 receptor agonist
ACTELION PHARMACEUTICALS LTD2 citations71
US8039644B2Oct 18, 2011
Hydrogenated benzo (C) thiophene derivatives as immunomodulators
ACTELION PHARMACEUTICALS LTD4 citations62
US7375227B2May 20, 2008
Quinoline derivatives
ACTELION PHARMACEUTICALS LTD2 citations62
US6815451B2Nov 9, 2004
1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
ACTELION PHARMACEUTICALS LTD2 citations62
US10660880B2May 26, 2020
Dosing regimen for a selective S1P1 agonist
ACTELION PHARMACEUTICALS LTD0 citations50
US10189839B2Jan 29, 2019
Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase
ACTELION PHARMACEUTICALS LTD0 citations37
US9765092B2Sep 19, 2017
Tricyclic piperidine compounds
ACTELION PHARMACEUTICALS LTD0 citations37
BOLLI MARTIN
13 patentsUS8299086B2Oct 30, 2012
Pyrimidine derivatives
BOLLI MARTIN14 citations84
US8288554B2Oct 16, 2012
Pyridin-3-yl derivatives as immunomodulating agents
BOLLI MARTIN15 citations84
US8178562B2May 15, 2012
Pyridine derivatives
BOLLI MARTIN10 citations84
US8148410B2Apr 3, 2012
Thiophene derivatives as agonists of S1P1/EDG1
BOLLI MARTIN11 citations84
US8133910B2Mar 13, 2012
Thiophene derivatives as S1P1/EDGE1 receptor agonists
BOLLI MARTIN16 citations84
US8658675B2Feb 25, 2014
Pyridin-4-yl derivatives
BOLLI MARTIN7 citations83
US8580824B2Nov 12, 2013
Pyridin-4-yl derivatives as immunomodulating agents
BOLLI MARTIN6 citations73
US8575200B2Nov 5, 2013
Pyridin-2-yl derivatives as immunomodulating agents
BOLLI MARTIN6 citations73
US8410151B2Apr 2, 2013
Aminomethyl benzene derivatives
BOLLI MARTIN6 citations73
US9133179B2Sep 15, 2015
2-methoxy-pyridin-4-yl-derivatives
BOLLI MARTIN5 citations72
US8598208B2Dec 3, 2013
Pyridine derivatives as S1P1/EDG1 receptor modulators
BOLLI MARTIN6 citations72
US8592460B2Nov 26, 2013
Amino-pyridine derivatives as S1P1 /EDG1 receptor agonists
BOLLI MARTIN6 citations72
US8697732B2Apr 15, 2014
Pyridine derivatives
BOLLI MARTIN4 citations71
BINKERT CHRISTOPH
4 patentsUS8273779B2Sep 25, 2012
Thiazolidin 4-one derivatives
BINKERT CHRISTOPH26 citations95
US8524752B2Sep 3, 2013
Thiazolidin-4-one derivatives
BINKERT CHRISTOPH22 citations92
USRE43833ENov 27, 2012
Thiazolidin-4-one derivatives
BINKERT CHRISTOPH21 citations92
USRE43728EOct 9, 2012
Thiazolidin-4-one derivatives
BINKERT CHRISTOPH25 citations92